Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pegah Masrori

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2021
Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosisPegah Masrori, Maxim De Schaepdryver, Mary Kay Floeter, et al.
European Journal of Neurology|March 7, 2022
Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutationPegah Masrori, Simona Ospitalieri, Karin Forsberg, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2021
Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 monthsPegah Masrori, Hannah Vaesen Bentein, Jo Raskin, et al.
Brain : a Journal of Neurology|March 8, 2023
Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosisAlberto Catanese, Sandeep Rajkumar, Daniel Sommer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Combined brain and spinal FDG PET in the differentiation between ALS and ALS mimics - correction and additional validation studyDonatienne Van Weehaeghe, Martijn Devrome, Joke de Vocht, et al.
Annals of Clinical and Translational Neurology|September 14, 2019
Serum neurofilament heavy chains as early marker of motor neuron degenerationMaxim De Schaepdryver, Janne Goossens, Steffi De Meyer, et al.
Cells|March 29, 2023
Differences in Cerebral Glucose Metabolism in ALS Patients with and without <i>C9orf72</i> and <i>SOD1</i> MutationsJoke De Vocht, Donatienne Van Weehaeghe, Fouke Ombelet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2022
Characterising ALS disease progression according to El Escorial and Gold Coast criteriaAdriaan D de Jongh, Nathalie Braun, Markus Weber, et al.
Molecular Neurodegeneration|January 18, 2023
FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanismsKatarina Stoklund Dittlau, Lisanne Terrie, Pieter Baatsen, et al.
Journal of Neurology|September 28, 2024
Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALSDelia Gagliardi, Mafalda Rizzuti, Pegah Masrori, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2021
Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosisPegah Masrori, Maxim De Schaepdryver, Mary Kay Floeter, et al.
European Journal of Neurology|March 7, 2022
Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutationPegah Masrori, Simona Ospitalieri, Karin Forsberg, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2021
Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 monthsPegah Masrori, Hannah Vaesen Bentein, Jo Raskin, et al.
Brain : a Journal of Neurology|March 8, 2023
Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosisAlberto Catanese, Sandeep Rajkumar, Daniel Sommer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Combined brain and spinal FDG PET in the differentiation between ALS and ALS mimics - correction and additional validation studyDonatienne Van Weehaeghe, Martijn Devrome, Joke de Vocht, et al.
Annals of Clinical and Translational Neurology|September 14, 2019
Serum neurofilament heavy chains as early marker of motor neuron degenerationMaxim De Schaepdryver, Janne Goossens, Steffi De Meyer, et al.
Cells|March 29, 2023
Differences in Cerebral Glucose Metabolism in ALS Patients with and without <i>C9orf72</i> and <i>SOD1</i> MutationsJoke De Vocht, Donatienne Van Weehaeghe, Fouke Ombelet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2022
Characterising ALS disease progression according to El Escorial and Gold Coast criteriaAdriaan D de Jongh, Nathalie Braun, Markus Weber, et al.
Molecular Neurodegeneration|January 18, 2023
FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanismsKatarina Stoklund Dittlau, Lisanne Terrie, Pieter Baatsen, et al.
Journal of Neurology|September 28, 2024
Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALSDelia Gagliardi, Mafalda Rizzuti, Pegah Masrori, et al.
Pageof 3